Absci | IPO Presentation Deck | 65 slides · page 26 of 65
The slide uses a continuous line path to group companies into 'Synthetic Biology' (sub-segments: Other industries, Biopharma) and 'AI Enabled Drug Discovery' (sub-segments: Proteins, Small molecules).
Pitch deck · competitive_analysis · compare_peers · balanced density
Slide locked Sign in to view
Slide schematic 3/3
diagram 1/1 paragraph 1/1 title 1/1
Components 3
other paragraph headline
Tools 1
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 1